J.R. Fitchett

Tissue Disposition of 2′‐O‐(2‐methoxy) ethyl Modified Antisense Oligonucleotides in Monkeys

Rosie Z. Yu, Richard S. Geary, David Monteith et al. · Journal of Pharmaceutical Sciences · 2003 · 104 citations

Tissue Disposition, Medicine, Oligonucleotide +4

Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-1 kinase expression.

Richard S. Geary, Janet M. Leeds, J.R. Fitchett et al. · PubMed · 1997 · 98 citations

Immunology, Pathology, Pharmacotherapy +18

Comparison of pharmacokinetics and tissue disposition of an antisense phosphorothioate oligonucleotide targeting human Ha‐ras mRNA in mouse and monkey

Rosie Z. Yu, Richard S. Geary, Janet M. Leeds et al. · Journal of Pharmaceutical Sciences · 2001 · 60 citations

Tissue Disposition, Medicine, Antisense Phosphorothioate +7

Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease

Robert J. Benschop, Chi-Kin Chow, Yu Tian et al. · mAbs · 2019 · 49 citations · Full text

Antiviral activity and ocular kinetics of antisense oligonucleotides designed to inhibit CMV replication.

Scott P. Henry, Richard C. Miner, William Drew et al. · PubMed · 2001 · 37 citations